Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism WRN inhibitors(WRN RecQ like helicase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization MOMA Therapeutics, Inc.Startup |
Active Organization MOMA Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | US | MOMA Therapeutics, Inc.Startup | 30 Aug 2024 |
Endometrial Carcinoma | Preclinical | US | MOMA Therapeutics, Inc.Startup | 30 Aug 2024 |
Stomach Cancer | Preclinical | US | MOMA Therapeutics, Inc.Startup | 30 Aug 2024 |